Bookbuilding IPO | ₹80 Cr | Listed at BSE | Mon, May 12, 2008 - Thu, May 15, 2008
Anu's Laboratories IPO is a book build issue of ₹80.22 crores. The issue is entirely a fresh issue of 0.38 crore shares of ₹80.22 crore.
Anu's Laboratories IPO bidding started from May 12, 2008 and ended on May 15, 2008. The shares got listed on BSE on Jun 4, 2008.
Anu's Laboratories IPO price band is set at ₹210 per share. The lot size for an application is 30. The minimum amount of investment required by an retail is ₹6,300 (30 shares) (based on upper price). The lot size investment for sNII is 32 lots (960 shares), amounting to ₹2,01,600, and for bNII, it is 159 lots (4,770 shares), amounting to ₹10,01,700.
The issue includes a reservation of up to 2,00,000 shares for employees offered at a discount of ₹0.00 to the issue price.
Almondz Global Securities Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.
Refer to Anu's Laboratories IPO RHP for detailed Information.
IPO Open
Mon, May 12, 2008
IPO Close
Thu, May 15, 2008
Issue Price
₹210 per share
Market Cap (Pre-IPO)
₹253.60 Cr
| IPO Date | 12 to 15 May, 2008 |
| Listed on | Wed, Jun 4, 2008 |
| Face Value | ₹10 per share |
| Price Band | ₹200 to ₹210 |
| Issue Price | ₹210 per share |
| Lot Size | 30 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE |
| Total Issue Size | 38,20,000 shares (agg. up to ₹80 Cr) |
| Fresh Issue | 38,20,000 shares (agg. up to ₹80 Cr) |
| Share Holding Pre Issue | 82,56,000 shares |
| Share Holding Post Issue | 1,20,76,000 shares |
| BSE Script Code | 532981 |
| ISIN | INE450H01014 |
Anu's Laboratories IPO comprises a total issue size of 38,20,000 shares. The net offer to the public is 36,20,000 shares, after excluding 2,00,000 shares under a preferential allotment. Of the Net offer 18,10,000 (50.00%) are allocated to QIB, 5,43,000 (15.00%) allocated to NII 12,67,000 (35.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue | Max Allottees |
|---|---|---|---|---|
| QIB Shares Offered | 18,10,000 | 50.00% | 47.38% | NA |
| NII (HNI) Shares Offered | 5,43,000 | 15.00% | 14.21% | NA |
| Retail Shares Offered | 12,67,000 | 35.00% | 33.17% | 42,233 |
| Preferential Reservations | ||||
| Employee Shares Offered | 2,00,000 | 5.24% | NA | |
| Total Shares Offered | 38,20,000 | 100.00% | 100.00% | |
Investors can bid for a minimum of 30 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 30 | ₹6,300 |
| Retail (Max) | 31 | 930 | ₹1,95,300 |
| S-HNI (Min) | 32 | 960 | ₹2,01,600 |
| S-HNI (Max) | 158 | 4,740 | ₹9,95,400 |
| B-HNI (Min) | 159 | 4,770 | ₹10,01,700 |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only RII | Up to Rs 2 Lakhs | Yes |
| Only sNII | Rs 2 Lakhs to Rs 10 Lakhs | No |
| Only bNII | Rs 10 Lakhs to NII Reservation Portion | No |
| Only employee | Yes | |
| Employee + RII/NII |
|
Yes for Employee and RII/NII |
Incorporated in 1996, Anu’s Laboratories Limited is an ISO 9001:2000 certified company, engaged in manufacture bulk active pharma ingredients and intermediates for drug molecules and was promoted by Mr. K. Hari Babu.
Company started their own manufacturing facilities in the year 1998 from Chilakamarri Village, Shadnagar, Mahboobnagar District, Andhra Pradesh with manufacturing of 2,4 Dichloro 5 Fluoro Acetophenone (DCFA). Company had started export of their products in the year 2002 to Israel followed by exports to other countries like Italy, Japan, France, USA and Singapore. Currently, exports comprise of 12.37% of total turnover.
They are engaged in manufacture of Basic & Advanced Intermediates and fine chemicals and are presently having manufacturing facilities for key intermediates like 2,4-Dichloro-5-Fluoro Acetophenone (DCFA) (an intermediate for synthesizing quinolone antibiotics like ciprofloxacin); Chlorohexanone (key intermediate in the manufacture of cardio vascular medicine) and Methyl-4 (4-Chloro 1 oxo butane) a, a Di-Methyl Acetate (an intermediate in the manufacture of Fexofenadine an anti allergic drug). DCFA have contributed 39.88% of our total sales whereas Methyl-4 (4-Chloro 1 oxo butane) a, a Di-Methyl Acetate contributed 18.30% and Chlorohexanone contributed 5.39% of the total sales during 2006- 07.
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Setting up a new plant for manufacturing of drug intermediates including Active Pharmaceutical Ingredients (APIs) | 55.09 |
| 2 | Setting up of pilot plant for carrying out Contract Research and Manufacturing (CRAM) | 8.34 |
| 3 | Meeting long term working capital requirement | 16.67 |
| 4 | Meeting general corporate purposes | 4.15 |
| 5 | Meeting Issue expenses | 7.97 |
The Anu Laboratories IPO is subscribed 8.43 times on May 15, 2008 5:00:00 PM (Day 4). The public issue subscribed 9.64 times in the retail category, 2.84 times in the QIB category, and 26.97 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Issue Management Fees, Brokerage & Selling Commission | 2.36 |
| 2 | Fees payable to Registrars to the Issue | 0.20 |
| 3 | Fee for Legal Advisors to the Issue | 0.08 |
| 4 | Fee payable to Grading Agency for grading the Issue | 0.06 |
| 5 | Printing and Distribution of Issue Stationery | 0.54 |
| 6 | Advertising and Marketing expenses | 0.45 |
| 7 | Other expenses (stamp duty, initial listing fees, depository fees, charges for using the book building software of the exchanges and other related expenses) | 4.28 |
Due to define rules by SEBI, Company has given an option to its investors to withdraw the application with in 10 days from May 16, 2008.
This may cause some delay in share allotment and refund for Anu's lab IPO. Investors who do not want to block their money may withdraw their IPO application in next 10 days.
Notice date: Tuesday, May 20, 2008
Anu's Laboratories Limited has come out with an initial public issue of 38,20,000 equity shares of Rs.10/- each through the Book Building Route. The Issue opened on May 12, 2008 and closed on May 15, 2008. Subsequent, to the closure of the public issue, the company has come out with a public notice dated May 16, 2008 in The Business Standard (all editions), Gujarat Samachar (all editions), Sandesh (all editions), Financial Express (all editions), Jansatta (all editions), Andhra Prabha (Hyderabad), Smart Investor (Ahmedabad), Rakhewal (North Gujarat), Akila (Rajkot), Alpviram (Ahmedabad), Western Times Group (English/Gujrati- Ahmedabad), Damanganga Times (Daman/Vapi), Bundu Daily (Ahmedabad), Gandhinagar Samachar (Gandhinagar), Humlog (Patan), Kesari Daily (Junagadh), Kutchh Uday (Katch), Nobat (Jamnagar), Vadodra Samachar (Vadodra) and Loktej(Surat). A copy of the same is enclosed herewith. Investors in the issue are requested to take note of the same.
Sydney Miranda
AGM- DCS
Tuesday, May 20, 2008
Read attached document Investorletter.pdf
| Price Details | BSE |
|---|---|
| Final Issue Price | ₹210.00 |
| Open | ₹260.00 |
| Low | ₹256.60 |
| High | ₹288.40 |
| Last Trade | ₹268.05 |
Lead Manager Reports
Anu's Laboratories IPO is a main-board IPO of 38,20,000 equity shares of the face value of ₹10 aggregating up to ₹80 Crores. The issue is priced at ₹210 per share. The minimum order quantity is 30.
The IPO opens on Mon, May 12, 2008, and closes on Thu, May 15, 2008.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE.
Zerodha customers can apply online in Anu's Laboratories IPO using UPI as a payment gateway. Zerodha customers can apply in Anu's Laboratories IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Anu's Laboratories IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Anu's Laboratories IPO opens on Mon, May 12, 2008 and closes on Thu, May 15, 2008.
Anu's Laboratories IPO lot size is 30, and the minimum amount required for application is ₹6,300.
You can apply in Anu's Laboratories IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Anu's Laboratories IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Anu's Laboratories IPO allotment status.
The Anu's Laboratories IPO listing date is on Wed, Jun 4, 2008.
